Molecular epidemiology and antiviral resistance characterization of Hepatitis C virus circulating in Africa and Brazil

QR Code

Molecular epidemiology and antiviral resistance characterization of Hepatitis C virus circulating in Africa and Brazil

Hepatitis C virus (HCV) infection is a public health problem that is responsible for liver disease and hepatocellular carcinoma Worldwide. Remarkable achievements have been made in the study of molecular epidemiology of HCV in industrialized countries, and this information is proving invaluable in...

Full description

Bibliographic Details
Main Author:	Adeboyejo, Kazeem Adeyinka
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2020
Subjects:	Hepatitis C virus; Molecular epidemiology; Phylogenetic analysis; Hepatitis C genotyping
Online Access:	https://eprints.nottingham.ac.uk/59967/

Similar Items

Effectiveness of an education intervention on Hepatitis C treatment adherence among Libyan patients in a medical center in Tripoli
by: Adam, Samia Ibrahim Mohamed
Published: (2018)

Risk factors for hepatitis c virus infection among adult patients at a public hospital in Kedah, Malaysia
by: Mohd Suan, Mohd Azri
Published: (2019)

Recombinant human L-ficolin directly neutralizes hepatitis C virus entry
by: Hamed, Mohamed R., et al.
Published: (2014)

Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease
by: Kendall, Timothy, et al.
Published: (2018)

Co-infections of hepatitis B patients with other hepatitis viruses and their serological, biological and prognostic markers
by: Hudu Abdullahi, Shuaibu
Published: (2017)

Preventing hepatitis C virus transmission among young people in the justice system
by: Lenton, E., et al.
Published: (2013)

Investigation of Hepatitis B virus entry mechanism
by: Raymond, Chidinma
Published: (2022)

Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1
by: Mesalam, Ahmed Atef, et al.
Published: (2018)

Outcomes after successful direct acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
by: Cheung, Michelle C.M., et al.
Published: (2016)

Comorbities and medications of patients with chronic hepatitis C under specialist care in the UK
by: Hudson, Benjamin, et al.
Published: (2017)

Authenticity and Diversity: Enhancing Australian Hepatitis C Prevention Messages
by: Winter, R., et al.
Published: (2013)

Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: a systematic review
by: Walker, Alex J., et al.
Published: (2018)

Harm reduction and hepatitis C: On the ethics and politics of prevention and treatment
by: Fraser, S., et al.
Published: (2011)

Hepatitis C treatment - better outcomes through partner support
by: Chapman, Fleur, et al.
Published: (2012)

Display of the pres regions of the surface antigen of Hepatitis B virus on M13 and T7 Bactetiophages
by: Kok, Wai Ling
Published: (2001)

Novel entry pathways for Hepatitis B virus
by: Parmar, Devan
Published: (2023)

High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease
by: Hedegaard, Ditte L., et al.
Published: (2017)

The interface between adaptive and innate neutralisation of virus entry: competition, addition or synergy?
by: Wartnaby, Sophie R.
Published: (2023)

Development of anti-hepatitis B virus core antigen biosensor using gold nanoparticle-decorated reduced graphene oxide
by: Abd Muain, Mohamad Farid
Published: (2019)

Expression, purification and structural characterisation of Hepatitis B virus core antigen with an N-terminal extension
by: Yoon, Kam Yee
Published: (2013)

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy
by: Backx, M., et al.
Published: (2014)

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
by: Thabet, Khaled, et al.
Published: (2016)

The effects of the human innate pattern recognition receptor L-ficolin and its variants against Hepatitis C virus infection
by: Mason, Christopher Paul
Published: (2019)

Recombinant hepatitis B virus core particles: association, dissociation and encapsidation of green fluorescent protein.
by: Lee, Khai Wooi, et al.
Published: (2008)

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo
by: Desombere, Isabelle, et al.
Published: (2017)

Molecular characterization and methylation status of torque teno virus isolation among hepatitis patients in a public hospital in Pahang, Malaysia
by: Hazanuddin, Siti Nurzulaikha
Published: (2020)

Selection of High Affinity Peptides Against Hepatitis B Core Antigen from a Phage-Displayed Cyclic Peptide Library
by: Ho, Kok Lian
Published: (2002)

Does informing people who inject drugs of their hepatitis C status influence their injecting behavior? Analysis of the Networks II study
by: Aspinall, E., et al.
Published: (2014)

Applications of phage peptide libraries for epitope discovery and identification of novel anti-virals
by: Hakami, Abdulrahim R.
Published: (2017)

Targeted delivery of short hairpin RNA expressing plasmid using hepatitis B virus-like particle for bcl-2 gene silencing in cervical cancer cells
by: Akwiditya, Made Angga
Published: (2021)

An evaluation of the opt-out approach to Hepatitis C Virus infection testing in prisons
by: Jack, Kathryn
Published: (2020)

Shielding of virus-like nanoparticles of hepatitis B core antigen by poly(2-oxazoline) for reduced antigenicity
by: Fam, See Yee
Published: (2021)

Detection of HCV-specific IFN-gamma responses in HCV antibody and HCV RNA negative injecting drug users
by: Flynn, J., et al.
Published: (2014)

Periportal CD4+ Cell Infiltration Increases in HIV/Hepatitis C Virus–Coinfected Patients Commencing ART, Whereas CD8+ Cells Clear From the Liver
by: Gani, R., et al.
Published: (2014)

Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs
by: O’Keefe, D., et al.
Published: (2013)

Targeted 5-fluorouracil-1-acetic acid delivery utilising cell penetrating peptide conjugated hepatitis b virus-like nanoparticles to squamous cell carcinoma A431
by: Gan, Bee Koon
Published: (2020)

The effects of probiotics and symbiotics on risk factors for hepatic encephalopathy
by: Viramontes Hörner, Daniela, et al.
Published: (2017)

Hepatitis B capsid as a delivery vehicle into mammalian cells
by: Lee, Khai Wooi
Published: (2012)

Development and application of the antigen microarray for the detection of autoantibodies in hepatocellular carcinoma patients
by: Afriyie-Asante, Afrakoma
Published: (2019)

Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7
by: Tan, Geok Hun, et al.
Published: (2005)